Shuofei Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shuofei Yang has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
- Baochen Liu
Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, Jiangsu Province, P. R. China
4 shared publications - Guanhua Xue
Department of Vascular Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
4 shared publications - Jieshou Li
Surgical Intensive Care Unit (SICU), Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
4 shared publications - Weiwei Ding
Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, Jiangsu Province 210094, China
4 shared publications - Changsheng He
Research Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University
3 shared publications - Jiaxiang Meng
Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, Jiangsu Province, P. R. China
3 shared publications
Latest Publications
- Open Access
- 8 August 2026
- Published by Springer Nature in Experimental Hematology & Oncology
- Vol. 15 (1) , 74
AAV-delivered miRNA-gated Cre circuits enable programmable gene activation in AFP-active liver tumor models
- 8 August 2026
- Published by Springer Nature in Experimental Hematology & Oncology
- Vol. 15 (1) , 74
Open AccessAAV-delivered miRNA-gated Cre circuits enable programmable gene activation in AFP-active liver tumor models
- Open Access
- 6 July 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Single-cell transcriptomics-guided dynamic hydrogel delivery of artemisia argyi-derived EVs relieves ER stress and promotes diabetic wound regeneration
Diabetic wounds are characterized by persistent inflammation, impaired angiogenesis, and delayed tissue regeneration, yet effective strategies to regulate
- 6 July 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Open AccessSingle-cell transcriptomics-guided dynamic hydrogel delivery of artemisia argyi-derived EVs relieves ER stress and promotes diabetic wound regeneration
Diabetic wounds are characterized by persistent inflammation, impaired angiogenesis, and delayed tissue regeneration, yet effective strategies to regulate
- 1 May 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 46 (5)
RNA Splicing of the FGFR2 Gene Promotes Endothelial Cell Senescence and Atherosclerosis Development
BACKGROUND: Endothelial cell (EC) senescence is intimately linked to the development and progression of atherosclerosis. The FGFR2 (fibroblast growth factor receptor 2) signaling is crucial in regulating the phenotype of ECs. Recent studies have revealed that cell phenotype–specific alternative splicing of FGFR2 premRNA (precursor mRNA) results in the mutually exclusive inclusion of either exon IIIb or IIIc, leading to critical differences in receptor function. This study aimed to investigate the role of FGFR2 alternative splicing in EC senescence and atherosclerosis development, and to elucidate the underlying mechanisms. METHODS: Clinical samples and animal models were used to assess the association between FGFR2-IIIc isoform expression and EC senescence as well as atherosclerotic plaque formation. The mechanisms underlying FGFR2-IIIc–induced EC senescence were elucidated through a combination of in vivo and in vitro investigations. In addition, genetically engineered mice with endothelial-specific overexpression or knockdown of FGFR2-IIIc were utilized to investigate the impact of FGFR2-IIIc on vascular endothelial senescence and the progression of atherosclerosis. RESULTS: Elevated expression of the FGFR2-IIIc isoform was detected in clinical samples and animal models of aging and atherosclerosis, where it correlated with both EC senescence and atherosclerotic plaque formation. Mechanistically, the alternative splicing–mediated switch from FGFR2-IIIb to FGFR2-IIIc established an FGF2–FGFR2-IIIc autocrine feedback loop, which drove ECs toward a senescence-associated secretory phenotype via the PKC (protein kinase C) ε/STAT3 (signal transducer and activator of transcription) pathway. Senescence-inducing stimuli promoted the binding of the splicing factor hnRNP H1 (heterogeneous nuclear ribonucleoprotein H1) to exon IIIb of the FGFR2 gene, leading to skipping of this exon. Notably, EC-specific knockout of FGFR2-IIIc in ApoE −/− mice reduced plaque area, suppressed senescence-associated secretory phenotype gene expression, and attenuated cellular senescence compared with controls. CONCLUSIONS: This study reveals that FGFR2 splicing mediated by hnRNP H1 promotes EC senescence and atherosclerosis via an FGF2–FGFR2-IIIc autocrine loop. These findings identify FGFR2-IIIc as a potential therapeutic target for age-related atherosclerosis.
- 1 May 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 46 (5)
RNA Splicing of the FGFR2 Gene Promotes Endothelial Cell Senescence and Atherosclerosis Development
BACKGROUND: Endothelial cell (EC) senescence is intimately linked to the development and progression of atherosclerosis. The FGFR2 (fibroblast growth factor receptor 2) signaling is crucial in regulating the phenotype of ECs. Recent studies have revealed that cell phenotype–specific alternative splicing of FGFR2 premRNA (precursor mRNA) results in the mutually exclusive inclusion of either exon IIIb or IIIc, leading to critical differences in receptor function. This study aimed to investigate the role of FGFR2 alternative splicing in EC senescence and atherosclerosis development, and to elucidate the underlying mechanisms. METHODS: Clinical samples and animal models were used to assess the association between FGFR2-IIIc isoform expression and EC senescence as well as atherosclerotic plaque formation. The mechanisms underlying FGFR2-IIIc–induced EC senescence were elucidated through a combination of in vivo and in vitro investigations. In addition, genetically engineered mice with endothelial-specific overexpression or knockdown of FGFR2-IIIc were utilized to investigate the impact of FGFR2-IIIc on vascular endothelial senescence and the progression of atherosclerosis. RESULTS: Elevated expression of the FGFR2-IIIc isoform was detected in clinical samples and animal models of aging and atherosclerosis, where it correlated with both EC senescence and atherosclerotic plaque formation. Mechanistically, the alternative splicing–mediated switch from FGFR2-IIIb to FGFR2-IIIc established an FGF2–FGFR2-IIIc autocrine feedback loop, which drove ECs toward a senescence-associated secretory phenotype via the PKC (protein kinase C) ε/STAT3 (signal transducer and activator of transcription) pathway. Senescence-inducing stimuli promoted the binding of the splicing factor hnRNP H1 (heterogeneous nuclear ribonucleoprotein H1) to exon IIIb of the FGFR2 gene, leading to skipping of this exon. Notably, EC-specific knockout of FGFR2-IIIc in ApoE −/− mice reduced plaque area, suppressed senescence-associated secretory phenotype gene expression, and attenuated cellular senescence compared with controls. CONCLUSIONS: This study reveals that FGFR2 splicing mediated by hnRNP H1 promotes EC senescence and atherosclerosis via an FGF2–FGFR2-IIIc autocrine loop. These findings identify FGFR2-IIIc as a potential therapeutic target for age-related atherosclerosis.
- Open Access
- 1 January 2026
- Published by Wiley in Stem Cells International
- Vol. 2026 (1) , 8147359
MSC‐EVs Prevent Abdominal Aortic Aneurysm Formation by Inhibiting Perivascular Adipose Tissue‐Induced NET Release
Background: Perivascular adipose tissue (PVAT) envelops arteries and exerts paracrine effects, thereby modulating cardiovascular pathologies. Nevertheless, its precise role in abdominal aortic aneurysm (AAAs) pathogenesis remains elusive. Mesenchymal stem cell‐derived extracellular vesicles (MSC‐EVs) have been implicated in the regulation of neutrophil extracellular traps (NETs) formation. This investigation delineates PVAT’s involvement in AAA, particularly in NETs regulation, and evaluates the modulatory impact of MSC‐EVs on these processes. Methods: A comprehensive analysis of CT imaging and clinical datasets from AAA patients was undertaken. Subsequent RNA sequencing and transcriptomic profiling of PVAT from AAA animal models and controls were conducted. Both in vivo and in vitro assays were employed to determine whether PVAT‐derived proteins influence NETs release within the abdominal aorta and contribute to AAA development. Additionally, MSC‐EVs were administered via intravenous or intraperitoneal routes to assess their effects on PVAT accumulation and NETs formation. Results: A significant correlation was established between PVAT characteristics and clinical outcomes in AAA patients. Experimental findings reveal that PVAT‐derived serum amyloid A (SAA) promotes PVAT accumulation and induces NETs release within the abdominal aorta during AAA formation. Intraperitoneal MSC‐EVs administration mitigates AAA development by reducing PVAT accumulation, suppressing SAA expression in PVAT, and inhibiting NETs formation in the abdominal aorta. Conclusion: PVAT‐derived SAA facilitates NETs formation during AAA pathogenesis. MSC‐EVs, by targeting these mechanisms, offer a promising prophylactic strategy against AAA, opening new therapeutic avenues for future research.
- 1 January 2026
- Published by Wiley in Stem Cells International
- Vol. 2026 (1) , 8147359
Open AccessMSC‐EVs Prevent Abdominal Aortic Aneurysm Formation by Inhibiting Perivascular Adipose Tissue‐Induced NET Release
Background: Perivascular adipose tissue (PVAT) envelops arteries and exerts paracrine effects, thereby modulating cardiovascular pathologies. Nevertheless, its precise role in abdominal aortic aneurysm (AAAs) pathogenesis remains elusive. Mesenchymal stem cell‐derived extracellular vesicles (MSC‐EVs) have been implicated in the regulation of neutrophil extracellular traps (NETs) formation. This investigation delineates PVAT’s involvement in AAA, particularly in NETs regulation, and evaluates the modulatory impact of MSC‐EVs on these processes. Methods: A comprehensive analysis of CT imaging and clinical datasets from AAA patients was undertaken. Subsequent RNA sequencing and transcriptomic profiling of PVAT from AAA animal models and controls were conducted. Both in vivo and in vitro assays were employed to determine whether PVAT‐derived proteins influence NETs release within the abdominal aorta and contribute to AAA development. Additionally, MSC‐EVs were administered via intravenous or intraperitoneal routes to assess their effects on PVAT accumulation and NETs formation. Results: A significant correlation was established between PVAT characteristics and clinical outcomes in AAA patients. Experimental findings reveal that PVAT‐derived serum amyloid A (SAA) promotes PVAT accumulation and induces NETs release within the abdominal aorta during AAA formation. Intraperitoneal MSC‐EVs administration mitigates AAA development by reducing PVAT accumulation, suppressing SAA expression in PVAT, and inhibiting NETs formation in the abdominal aorta. Conclusion: PVAT‐derived SAA facilitates NETs formation during AAA pathogenesis. MSC‐EVs, by targeting these mechanisms, offer a promising prophylactic strategy against AAA, opening new therapeutic avenues for future research.
- Open Access
- 23 December 2025
- Published by Elsevier in Materials Today Bio
- Vol. 36, 102714
Targeting single-cell multiomics-identified vascular impairment: Panax notoginseng extracellular vesicles-loaded adhesive QBK-2/EVs promotes angiogenesis in diabetic wound healing
- 23 December 2025
- Published by Elsevier in Materials Today Bio
- Vol. 36, 102714
Open AccessTargeting single-cell multiomics-identified vascular impairment: Panax notoginseng extracellular vesicles-loaded adhesive QBK-2/EVs promotes angiogenesis in diabetic wound healing
- Open Access
- 28 November 2025
- Published by Elsevier in Materials Today Bio
- Vol. 35
Hydrogel-Wrapped Calendula officinalis L. extracellular vesicles - A novel approach to enhance fracture healing by Macrophage reprogramming
- 28 November 2025
- Published by Elsevier in Materials Today Bio
- Vol. 35
Open AccessHydrogel-Wrapped Calendula officinalis L. extracellular vesicles - A novel approach to enhance fracture healing by Macrophage reprogramming
- 2 August 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (27) , e01742
Viola Yedoensis Makino‐Derived Exosome‐Like Nanovesicles‐Loaded Adhesive Promotes Diabetic Fracture Healing via Anti‐Inflammatory Properties
Fracture management in patients with diabetes mellitus presents a significant clinical challenge, often resulting in nonunion or delayed fracture healing due to dysregulation of macrophage polarization and a persistent inflammatory microenvironment. While traditional internal fixation provides fracture stabilization, it exhibits limited ability to modulate the inflammatory microenvironment, thereby limiting bone regeneration. In this study, a bioadhesive hydrogel (DPC‐3) incorporating Viola yedoensis Makino‐derived exosome‐like nanovesicles (VDNPs) is developed to enhance fracture healing through localized immunomodulation. The hydrogel, synthesized via a Schiff base reaction between polyacrylamide (Pam), dialdehyde starch, and 30% oxidized chondroitin sulfate, exhibited robust tissue adhesion, mechanical stability, and sustained VDNPs release. Mechanistically, VDNPs facilitated M2 macrophage polarization through downregulation of the NF‐κB signaling pathway, mitigating inflammation and promoting osteogenesis. In a diabetic femoral fracture model, the DPC‐3/VDNPs hydrogel significantly accelerated bone regeneration compared to conventional treatments, evidenced by enhanced bone mineral density, volume fraction, and trabecular thickness, alongside histological analyses demonstrating increased osteogenesis and collagen deposition. Overall, these findings highlight the potential of the DPC‐3/VDNPs hydrogel as a promising therapeutic strategy for improving diabetic fracture healing outcomes by integrating mechanical support with biological activity derived from natural sources.
- 2 August 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (27) , e01742
Viola Yedoensis Makino‐Derived Exosome‐Like Nanovesicles‐Loaded Adhesive Promotes Diabetic Fracture Healing via Anti‐Inflammatory Properties
Fracture management in patients with diabetes mellitus presents a significant clinical challenge, often resulting in nonunion or delayed fracture healing due to dysregulation of macrophage polarization and a persistent inflammatory microenvironment. While traditional internal fixation provides fracture stabilization, it exhibits limited ability to modulate the inflammatory microenvironment, thereby limiting bone regeneration. In this study, a bioadhesive hydrogel (DPC‐3) incorporating Viola yedoensis Makino‐derived exosome‐like nanovesicles (VDNPs) is developed to enhance fracture healing through localized immunomodulation. The hydrogel, synthesized via a Schiff base reaction between polyacrylamide (Pam), dialdehyde starch, and 30% oxidized chondroitin sulfate, exhibited robust tissue adhesion, mechanical stability, and sustained VDNPs release. Mechanistically, VDNPs facilitated M2 macrophage polarization through downregulation of the NF‐κB signaling pathway, mitigating inflammation and promoting osteogenesis. In a diabetic femoral fracture model, the DPC‐3/VDNPs hydrogel significantly accelerated bone regeneration compared to conventional treatments, evidenced by enhanced bone mineral density, volume fraction, and trabecular thickness, alongside histological analyses demonstrating increased osteogenesis and collagen deposition. Overall, these findings highlight the potential of the DPC‐3/VDNPs hydrogel as a promising therapeutic strategy for improving diabetic fracture healing outcomes by integrating mechanical support with biological activity derived from natural sources.
- Open Access
- 1 February 2025
- Published by KEAI Publishing in Bioactive Materials
- Vol. 44, 236-255
Preventing postsurgical colorectal cancer relapse: A hemostatic hydrogel loaded with METTL3 inhibitor for CAR-NK cell therapy
Colorectal cancer (CRC) recurrence post-surgery remains a major challenge. While Chimeric Antigen Receptor (CAR)-engineered natural killer (NK) cells hold immense therapeutic potential, their intratumoral infiltration ability remains limited, hampering efficacy. Building upon prior research suggesting that chemokines like C-X-C motif chemokine ligand 9 (CXCL9) and C-X-C motif chemokine ligand 10 (CXCL10) recruit CAR-NK cells, we hypothesized that tumor cell m6A methylation, regulated by Methyltransferase-like 3 (METTL3), influences chemokine secretion. This study aims to elucidate the underlying mechanisms and improve METTL3 inhibition efficiency. We designed an adhesive hemostasis hydrogel loaded with STM2457, a METTL3 inhibitor, aimed at sustained release in the acidic tumor microenvironment. In vitro, the hydrogel promoted CAR-NK cell recruitment and tumor killing via sustained METTL3 inhibition. The hydrogel's Schiff base bonds further enabled intestinal adhesion and hemostasis in an incomplete tumor resection model of CRC. Combining the hydrogel with CAR-NK cell therapy significantly reduced CRC recurrence in vivo. Overall, our study reveals the crucial role of METTL3 in CRC recurrence and proposes a promising, multimodal strategy using STM2457-loaded hydrogel and CAR-NK cells for enhanced therapeutic efficacy.
- 1 February 2025
- Published by KEAI Publishing in Bioactive Materials
- Vol. 44, 236-255
Open AccessPreventing postsurgical colorectal cancer relapse: A hemostatic hydrogel loaded with METTL3 inhibitor for CAR-NK cell therapy
Colorectal cancer (CRC) recurrence post-surgery remains a major challenge. While Chimeric Antigen Receptor (CAR)-engineered natural killer (NK) cells hold immense therapeutic potential, their intratumoral infiltration ability remains limited, hampering efficacy. Building upon prior research suggesting that chemokines like C-X-C motif chemokine ligand 9 (CXCL9) and C-X-C motif chemokine ligand 10 (CXCL10) recruit CAR-NK cells, we hypothesized that tumor cell m6A methylation, regulated by Methyltransferase-like 3 (METTL3), influences chemokine secretion. This study aims to elucidate the underlying mechanisms and improve METTL3 inhibition efficiency. We designed an adhesive hemostasis hydrogel loaded with STM2457, a METTL3 inhibitor, aimed at sustained release in the acidic tumor microenvironment. In vitro, the hydrogel promoted CAR-NK cell recruitment and tumor killing via sustained METTL3 inhibition. The hydrogel's Schiff base bonds further enabled intestinal adhesion and hemostasis in an incomplete tumor resection model of CRC. Combining the hydrogel with CAR-NK cell therapy significantly reduced CRC recurrence in vivo. Overall, our study reveals the crucial role of METTL3 in CRC recurrence and proposes a promising, multimodal strategy using STM2457-loaded hydrogel and CAR-NK cells for enhanced therapeutic efficacy.
- Top Cited PapersOpen Access
- 1 January 2024
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 20 (9) , 3515-3529
Mesenchymal stem cell-derived extracellular vesicles accelerate diabetic wound healing by inhibiting NET-induced ferroptosis of endothelial cells
Impaired angiogenesis is a major factor contributing to delayed wound healing in diabetes. Dysfunctional mitochondria promote the formation of neutrophil extracellular traps (NETs), obstructing angiogenesis during wound healing. Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have shown promise in promoting tissue repair and regeneration in diabetes; however, the precise pathways involved in this process remain unclear. In this study, NET-induced ferroptosis of endothelial cells (ECs) and angiogenesis were assessed in diabetic wound samples from both patients and animal models. In vitro and in vivo experiments were performed to examine the regulatory mechanisms of NETs in ECs using specific inhibitors and gene-knockout mice. MSC-EVs encapsulating dysfunctional mitochondria were used to trigger mitochondrial fusion and restore mitochondrial function in neutrophils to suppress NET formation. Angiogenesis in wound tissue was evaluated using color laser Doppler imaging and vascular density analysis. Wound healing was evaluated via macroscopic analysis and histological evaluation of the epithelial gap. NET-induced ferroptosis of ECs was validated as a crucial factor contributing to the impairment of angiogenesis in diabetic wounds. Mechanistically, NETs regulated ferroptosis by suppressing the PI3K/AKT pathway. Furthermore, MSC-EVs transferred functional mitochondria to neutrophils in wound tissue, triggered mitochondrial fusion, and restored mitochondrial function, thereby reducing NET formation. These results suggest that inhibiting NET formation and EC ferroptosis or activating the PI3K/AKT pathway can remarkably improve wound healing. In conclusion, this study reveals a novel NET-mediated pathway involved in wound healing in diabetes and suggests an effective therapeutic strategy for accelerating wound healing.
- 1 January 2024
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 20 (9) , 3515-3529
Top Cited PapersOpen AccessMesenchymal stem cell-derived extracellular vesicles accelerate diabetic wound healing by inhibiting NET-induced ferroptosis of endothelial cells
Impaired angiogenesis is a major factor contributing to delayed wound healing in diabetes. Dysfunctional mitochondria promote the formation of neutrophil extracellular traps (NETs), obstructing angiogenesis during wound healing. Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have shown promise in promoting tissue repair and regeneration in diabetes; however, the precise pathways involved in this process remain unclear. In this study, NET-induced ferroptosis of endothelial cells (ECs) and angiogenesis were assessed in diabetic wound samples from both patients and animal models. In vitro and in vivo experiments were performed to examine the regulatory mechanisms of NETs in ECs using specific inhibitors and gene-knockout mice. MSC-EVs encapsulating dysfunctional mitochondria were used to trigger mitochondrial fusion and restore mitochondrial function in neutrophils to suppress NET formation. Angiogenesis in wound tissue was evaluated using color laser Doppler imaging and vascular density analysis. Wound healing was evaluated via macroscopic analysis and histological evaluation of the epithelial gap. NET-induced ferroptosis of ECs was validated as a crucial factor contributing to the impairment of angiogenesis in diabetic wounds. Mechanistically, NETs regulated ferroptosis by suppressing the PI3K/AKT pathway. Furthermore, MSC-EVs transferred functional mitochondria to neutrophils in wound tissue, triggered mitochondrial fusion, and restored mitochondrial function, thereby reducing NET formation. These results suggest that inhibiting NET formation and EC ferroptosis or activating the PI3K/AKT pathway can remarkably improve wound healing. In conclusion, this study reveals a novel NET-mediated pathway involved in wound healing in diabetes and suggests an effective therapeutic strategy for accelerating wound healing.